JPMORGAN CHASE & CO - VALEANT PHARMACEUTICALS INTE ownership

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of VALEANT PHARMACEUTICALS INTE
ValueSharesWeighting
Q2 2015$30,879,000
-75.3%
139,000
-77.9%
0.01%
-75.0%
Q1 2015$124,932,000
+20.5%
629,000
-13.2%
0.03%
+16.7%
Q4 2014$103,683,000
+165.7%
724,500
+143.6%
0.02%
+166.7%
Q3 2014$39,025,000297,4470.01%
Other shareholders

There were no reported owners of VALEANT PHARMACEUTICALS INTE in Q3 2015.

NameSharesValueWeighting ↓
View complete list of VALEANT PHARMACEUTICALS INTE shareholders